AstraZeneca completes global licence agreement for Zegfrovy

AstraZeneca and Daiichi Sankyo's Enhertu plus pertuzumab approved in EU for first-line HER2-positive metastatic breast cancer

NeuroSense reveals strategy to advance PrimeC toward potential ALS approval

UCB agrees with US government to lower medicine costs and strengthen US manufacturing

Karyopharm seeks accelerated FDA approval for selinexor–ruxolitinib in myelofibrosis

Juul Labs issues marketing granted orders for next generation JUUL2 System with tobacco- and menthol-flavoured pods

Ascletis Pharma Inc doses first participant in global Phase III clinical programme of ASC30

Zambon receives European Commission approval for Hopledo in Parkinson's disease

Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine

ReviR Therapeutics' RTX-117 receives FDA Rare Pediatric Disease Designation for Charcot-Marie-Tooth disease

Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic GEA eligible for ZIIHERA

Annovis Bio schedules corporate update webinar for next week

Cellenkos' CK0803 granted US FDA Fast Track designation for ALS

FDA approves Johnson & Johnson's IMAAVY (nipocalimab-aahu) to treat warm autoimmune haemolytic anaemia

Labcorp to offer FDA-cleared pTau-217 blood test for Alzheimer's assessment